Search Results for: Macchiarini

Positive regenerative medicine story of the year: diabetes & sickle cell were tops

/ / Leave a Comment
regenerative medicine

What was the biggest upbeat regenerative medicine story of 2024? I have my own favorites but decided to run a poll. Just putting the poll together, it was evident that this year was unusually full of good and encouraging news. Diabetes and sickle cell regenerative medicine therapies In The Niche polling, so far Vertex Type […]

Positive regenerative medicine story of the year: diabetes & sickle cell were tops Read More »

Poll on stem cell & regenerative medicine good news of 2024

/ / 1 Comment
stem cell good news, good news

What are the most significant stem cell and regenerative medicine good news stories of 2024? Since it has been an eventful year, there are many possibilities. Please see our poll at the bottom of this post and weigh in on what you think is the most important encouraging news. If you don’t see your choice

Poll on stem cell & regenerative medicine good news of 2024 Read More »

20 stem cell & regenerative medicine predictions for 2024

/ / 4 Comments
Stem cell, crystal ball, predictions

Each year I make predictions for the stem cell and regenerative medicine field for the following year. Today’s prediction post is focused on what to expect in 2024. You can also see my stem cell predictions for 2023 and my grades on how I did. I also have made a video version of these predictions so please

20 stem cell & regenerative medicine predictions for 2024 Read More »

2023 stem cell predictions grades reflect wild year for regenerative medicine

/ / 1 Comment
stem cell predictions

Every year I make stem cell and regenerative medicine predictions. Looking at my predictions for 2023, they reflect a wild year but in many ways a good one overall. Below I have graded my 2023 predictions. Overall, my crystal ball gave solid results. Some of the predictions have been condensed to keep things concise, but you

2023 stem cell predictions grades reflect wild year for regenerative medicine Read More »

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic

/ / Leave a Comment
Retraction watch

Retraction Watch has been a great resource for those of us who have been following research misconduct. They widely cover and conduct research on retractions, corrections, and other developments in this space. Unfortunately, there’s been plenty to write about even just within the stem cell and cell therapy arena, which is my primary interest. Think

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic Read More »

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates

/ / Leave a Comment
dr. jeffrey weiss, MD Stem Cells

There is still plenty of reason to worry about unproven stem cells being marketed in the U.S. and elsewhere around the world. I’ll start with a new item here in the U.S. on a firm called MD Stem Cells and end with a newly published paper about how things are going in Poland on this

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates Read More »

Trends in retractions as AI arms race on misconduct looms

/ / 3 Comments
stem cell paper retractions, retraction watch

There has been a big jump in paper retractions in science over the last 20 years. What’s going on? How do the trends in the stem cell field compare to other fields like cancer research and more broadly? Is AI going to change the dynamic between those engaging in misconduct and those who are looking for misconduct

Trends in retractions as AI arms race on misconduct looms Read More »

2nd chances after big misconduct? He Jiankui, James Wilson, others

/ / 3 Comments
James Wilson, Gene therapy

There have been rare instances like with scientist James Wilson where researchers were involved in what I would call major misconduct but somehow managed to bounce back. In a sense, they were given second chances in part by regulators but also by other scientists or supporters. However, after extraordinary misconduct, especially contributing to the death

2nd chances after big misconduct? He Jiankui, James Wilson, others Read More »

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more

/ / 1 Comment
Paolo-Macchiarini

Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if he might consider trying unproven stem cells or

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more Read More »